Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Chinese Journal of Applied Physiology ; (6): 222-226, 2010.
Article in Chinese | WPRIM | ID: wpr-340188

ABSTRACT

<p><b>OBJECTIVE</b>To study the effect of anti-basic jibroblast grouth factor (bFGF) on bleomycin-induced pulmonary fibrosis in rats and its possible mechanism.</p><p><b>METHODS</b>Pulmonary fibrosis was induced in Wistar rats by intratracheal instillation of bleomycin (model group, group M). Then the rats received anti-bFGF on 1, 2, 3, 8, 12, 19, 25 days intracavitary injection (group K), normal saline(group C) orally. Normal controls received normal saline both intratracheally and orally. Five rats in each group were sacrificed on 1.4 week after intratracheal instillation. Histological changes of the lungs were evaluated by HE stain and Massons trichrome stain. Lung expression of bFGF proteins was assessed by immunohistochemistry and the level of bFGF protein in serum and BALF was further measured by ELISA.</p><p><b>RESULTS</b>Pulmonary fibrosis of group M was higher than that of group C. bFGF in group M was higher than that in group C in lung, serum and BALF on 1.4 week. Pulmonary fibrosis of group K was lower than that of group M. bFGF in group K was lower than that in group M in lung, serum and BALF on 1.4 week.</p><p><b>CONCLUSION</b>Anti-bFGF alleviates bleomycin-induced pulmonary fibrosis in rats. Inhibiting the expressions of bFGF in lung tissues may be one of the mechanisms.</p>


Subject(s)
Animals , Female , Rats , Antibodies , Allergy and Immunology , Pharmacology , Bleomycin , Fibroblast Growth Factor 2 , Allergy and Immunology , Pulmonary Fibrosis , Metabolism , Random Allocation , Rats, Wistar
2.
Chinese Journal of Applied Physiology ; (6): 330-333, 2010.
Article in Chinese | WPRIM | ID: wpr-340158

ABSTRACT

<p><b>OBJECTIVE</b>To study the effect of inhalation of glucocorticoid on bleomycin-induced pulmonary fibrosis in rats and its possible mechanism.</p><p><b>METHODS</b>Pulmonary fibrosis was induced in Wistar rats by intratracheal instillation of bleomycin (group M, group B, group D). Group B inhaled glucocorticoid daily from the next day of received bleomycin. Group D intraperitoneal injection glucocorticoid daily from the next day of received bleomycin. Normal controls received normal saline both intratracheally. Five rats in each group were killed at 1, 4 week after intratracheal instillation. Histological changes of the lungs were evaluated by HE, Masson trichrome stain. Lung expression of bFGF proteins was assessed by immunohistochemistry and the level of bFGF protein in serum and BALF was further measured by ELISA.</p><p><b>RESULTS</b>Pulmonary fibrosis of group M was higher than that of group C, pulmonary fibrosis of group B, D was lower than that of group M at 1, 4 week. bFGF in group M was higher than that in group C, bFGF in group B, D was lower than that in group M in lung, serum and BALF on 1, 4 week.</p><p><b>CONCLUSION</b>Inhalation of glucocorticosteroid alleviates bleomycin-induced pulmonary fibrosis in rats. The mechanism may be related to the changes that bFGF is degrade or prevent it step up.</p>


Subject(s)
Animals , Male , Rats , Administration, Inhalation , Fibroblast Growth Factor 2 , Metabolism , Glucocorticoids , Therapeutic Uses , Pulmonary Fibrosis , Drug Therapy , Metabolism , Pathology , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL